Jim Simons
XBIO icon

Jim Simons’s Xenetic Biosciences XBIO Stock Holding History

Jim Simons’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$368K Sell
137,440
-41,069
-23% -$101K ﹤0.01% 2732
2025
Q4 		$387K Buy
178,509
+149,559
+517% +$477K ﹤0.01% 2677
2025
Q3 		$90.9K Buy
28,950
+4,200
+17% +$13.7K ﹤0.01% 3266
2025
Q2 		$97K Sell
24,750
-2,014
-8% -$5.82K ﹤0.01% 3301
2025
Q1 		$69.9K Buy
26,764
+1,214
+5% +$4.75K ﹤0.01% 3243
2024
Q4 		$102K Buy
25,550
+9,700
+61% +$39.1K ﹤0.01% 3283
2024
Q3 		$68.5K Buy
+15,850
New +$62.4K ﹤0.01% 3314
2023
Q3 		– Sell
-25,782
Closed -$85K – 4171
2023
Q2 		$85K Buy
25,782
+15,831
+159% +$59K ﹤0.01% 3508
2023
Q1 		$40K Sell
9,951
-4,389
-31% -$21.3K ﹤0.01% 3707
2022
Q4 		$41K Buy
14,340
+2,830
+25% +$12.5K ﹤0.01% 3841
2022
Q3 		$62K Sell
11,510
-3,596
-24% -$28.4K ﹤0.01% 3704
2022
Q2 		$121K Sell
15,106
-4,035
-21% -$32.6K ﹤0.01% 3799
2022
Q1 		$195K Sell
19,141
-6,981
-27% -$72.8K ﹤0.01% 3659
2021
Q4 		$337K Sell
26,122
-15,767
-38% -$252K ﹤0.01% 3289
2021
Q3 		$859K Buy
41,889
+27,767
+197% +$757K ﹤0.01% 2631
2021
Q2 		$288K Sell
14,122
-10,993
-44% -$222K ﹤0.01% 3159
2021
Q1 		$548K Buy
25,115
+8,095
+48% +$213K ﹤0.01% 2877
2020
Q4 		$347K Buy
17,020
+11,099
+187% +$134K ﹤0.01% 2985
2020
Q3 		$54K Sell
5,921
-11,399
-66% -$123K ﹤0.01% 3269
2020
Q2 		$177K Buy
17,320
+908
+6% +$8.62K ﹤0.01% 3186
2020
Q1 		$122K Buy
16,412
+4,332
+36% +$50.3K ﹤0.01% 3191
2019
Q4 		$174K Buy
+12,080
New +$153K ﹤0.01% 3221

Other funds holding XBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
DWM
Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

Jim Simons's XBIO Position: Q1 2026 in Review

Jim Simons reduced its Xenetic Biosciences (XBIO) stake by 23% in Q1 2026, selling an estimated $101K and leaving 137,440 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

Jim Simons first reported a position in XBIO in Q4 2019 and has held it in 22 quarters since. The position peaked at $859K in Q3 2021. 6 funds tracked by Wall St. Rank hold XBIO as of Q1 2026.

  • Jim Simons held 137,440 shares of Xenetic Biosciences worth $368K as of Q1 2026.
  • Jim Simons sold 41,069 Xenetic Biosciences shares in Q1 2026, an estimated $101K.
  • Xenetic Biosciences made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2732 holding.
  • Jim Simons first reported a position in Xenetic Biosciences in Q4 2019 and has held it in 22 quarters since.
  • Jim Simons's Xenetic Biosciences position peaked at $859K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.